Enauto Ventures

Enauto Ventures is a California-based venture capital fund founded in 2018 in Los Angeles, focused on AI and data-driven investments in life sciences, healthcare, and human behavior. The firm backs businesses that improve the daily human experience through artificial intelligence, with sector concentrations in medical diagnostics, therapeutics, health IT, biotech, medical devices, and pharmaceuticals. Co-founded by Alexandre Perrin and led by Managing Partner Eirini Schlosser, the firm deployed checks of $1 million to $8 million with a sweet spot of $3 million at Seed and Series A stages. Enauto made 9 investments across healthtech, AI and deep tech, biotech, and pharma, targeting companies using data and machine learning to advance clinical and commercial outcomes. The firm supported founders with deep operational, strategic, and technological guidance and facilitated global expansion through a network of executives, veteran investors, and seasoned entrepreneurs across international markets. Enauto Ventures is listed as inactive. During its operational period the firm represented a focused effort to connect advanced AI methodology with life sciences applications, a thesis that has since gained significant mainstream venture attention. The founders' backgrounds in technology and life sciences gave the firm a differentiated perspective on companies operating at the intersection of data science, diagnostics, and therapeutic innovation.